http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017081728-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fcdab57930cafaf53088e9cc804fdec |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6809 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2016-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3abfdb379eabd0f6def76296088c18b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_679c7cb78c11af7609e7bb23ca3ec07a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7732c04e324900e4287c43178d6e97c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c59a3fff40b451857955cbfa3189425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1765d510a7b58f115f7fede18d2b76b7 |
publicationDate | 2017-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2017081728-A1 |
titleOfInvention | Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancer |
abstract | A method for predicting a response to and/or benefit of chemotherapy, including neoadjuvant chemotherapy, in a patient suffering from or at risk of developing recurrent neoplastic disease, in particular breast cancer, said method comprising the steps of: n (a) determining in a tumor sample from said patient the RNA expression levels of the following 8 genes: UBE2C, RACGAP1, DHCR7, STC2, AZGP1, RBBP8, IL6ST, and MGP, indicative of a response to chemotherapy for a tumor, orn n(b) determining in a tumor sample from said patient the RNA expression levels of the following 8 genes: UBE2C, BIRC5, DHCR7, STC2, AZGP1, RBBP8, IL6ST, and MGP; indicative of a response to chemotherapy for a tumorn n(c) mathematically combining expression level values for the genes of the said set which values were determined in the tumor sample to yield a combined score, wherein said combined score is predicting said response and/or benefit of chemotherapy. |
priorityDate | 2011-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1810.